Cancer Biology & Medicine2026，Vol.23Issue(1)：P.15-20,6.DOI:10.20892/j.issn.2095-3941.2025.0641
Rethinking anti-cancer drug discovery:the evolution from polypharmacy to unified drug units
Jun He 1Xinbing Sui2
作者信息
- 1. Department of Medical Oncology,The Affiliated Hospital of Hangzhou Normal University,Hangzhou 310015,China
- 2. Department of Medical Oncology,The Affiliated Hospital of Hangzhou Normal University,Hangzhou 310015,China School of Pharmacy,Hangzhou Normal University,Hangzhou 311121,China
- 折叠
摘要
关键词
artificially intelligent synergistic engineered drug aised paradigmmerits/treatment strategythe/toxicity/unified drug units/combination therapies/drug resistance/anti cancer drug discovery/polypharmacy分类
医药卫生引用本文复制引用
Jun He,Xinbing Sui..Rethinking anti-cancer drug discovery:the evolution from polypharmacy to unified drug units[J].Cancer Biology & Medicine,2026,23(1):P.15-20,6.
